Varex Imaging Reports 5% Revenue Growth Despite Financial Losses in Q1 Fiscal 2025

Varex Imaging Reports Steady Growth Amidst Financial Challenges

Varex Imaging Corporation, a leading provider in the medical imaging and industrial X-ray markets, announces its unaudited financial results for the first quarter of fiscal year 2025, showcasing a commendable revenue growth of 5% year-over-year. The company records revenues of $200 million, driven mainly by its medical segment, which contributes $145 million in revenue—a 3% increase from the previous year. The industrial segment also demonstrates strength, achieving a revenue of $55 million, an impressive 10% rise. CEO Sunny Sanyal emphasizes the solid demand across both segments, attributing the higher profitability to a favorable sales mix and significant productivity gains.

Despite these positive figures, Varex encounters a GAAP net loss of $0.01 per diluted share, a stark contrast to its non-GAAP net earnings which rise to $0.07 per diluted share, up from $0.06 in the comparable quarter of the previous fiscal year. The company’s gross margins reflect this mixed performance; GAAP gross margin stands at 34%, while the non-GAAP gross margin is slightly better at 35%. Operating margins also show a divergence, with GAAP operating margin at 6% and non-GAAP at 7%. This duality underscores the complexities in Varex's financial landscape as it navigates through operational challenges while capitalizing on market opportunities.

Varex's cash flow from operations stands at $10 million, which reflects the company's capacity to generate cash amidst fluctuating earnings. The financial stability is further highlighted by the total cash, cash equivalents, and marketable securities amounting to $219 million at the end of the quarter, increasing from $213 million at the end of fiscal year 2024. Looking forward, Varex sets its revenue expectations for the second quarter of fiscal 2025 between $200 million and $215 million. However, the company acknowledges the uncertainties in providing a GAAP forecast, which could significantly impact net income due to reconciling items. The upcoming earnings conference call, scheduled for 3:00 p.m. Mountain Time, will provide further insights into Varex's strategic direction and financial outlook.

In the face of a dynamic market environment, Varex Imaging remains resilient, leveraging its solid product demand to drive growth. The company's commitment to enhancing productivity while managing cost structures positions it well to meet future challenges. As Varex prepares for the second quarter, its strategic focus on innovation and operational efficiency will be critical components in sustaining its upward trajectory in the imaging sector.